DURANTE MANGONI, Emanuele
 Distribuzione geografica
Continente #
NA - Nord America 5.987
EU - Europa 5.818
AS - Asia 578
Continente sconosciuto - Info sul continente non disponibili 16
SA - Sud America 12
OC - Oceania 7
AF - Africa 3
Totale 12.421
Nazione #
US - Stati Uniti d'America 5.966
IE - Irlanda 1.937
UA - Ucraina 1.087
GB - Regno Unito 864
IT - Italia 522
SE - Svezia 482
CN - Cina 299
FI - Finlandia 286
DE - Germania 245
TR - Turchia 220
GR - Grecia 193
FR - Francia 129
BE - Belgio 20
EU - Europa 16
IN - India 14
KR - Corea 12
RU - Federazione Russa 12
CA - Canada 11
MK - Macedonia 10
MX - Messico 10
NL - Olanda 7
BR - Brasile 6
AU - Australia 5
ES - Italia 5
SG - Singapore 5
JP - Giappone 4
PH - Filippine 4
SA - Arabia Saudita 4
AR - Argentina 3
CO - Colombia 3
CZ - Repubblica Ceca 3
IR - Iran 3
JO - Giordania 3
BG - Bulgaria 2
CH - Svizzera 2
DK - Danimarca 2
MY - Malesia 2
NZ - Nuova Zelanda 2
PL - Polonia 2
PT - Portogallo 2
RO - Romania 2
RS - Serbia 2
TW - Taiwan 2
AL - Albania 1
AT - Austria 1
EG - Egitto 1
ID - Indonesia 1
IL - Israele 1
KW - Kuwait 1
NP - Nepal 1
TH - Thailandia 1
TN - Tunisia 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 12.421
Città #
Dublin 1.936
Jacksonville 1.671
Chandler 1.010
Princeton 337
Roxbury 275
Cambridge 207
Boardman 187
Woodbridge 171
Ann Arbor 135
Medford 135
New York 128
Wilmington 124
Ashburn 85
Mountain View 85
Des Moines 67
San Mateo 63
Beijing 62
Nanjing 50
Jinan 34
Marano Di Napoli 32
Düsseldorf 28
Norwalk 26
Brussels 20
Bremen 18
Nanchang 17
Shenyang 17
Houston 16
Milan 16
Washington 16
Caserta 14
Venice 14
Hebei 12
Helsinki 12
Bologna 11
Kunming 11
Rome 11
Taiyuan 11
Napoli 10
Tianjin 10
Zhengzhou 10
Changsha 9
Naples 9
Pune 9
Guadalupe 8
Ningbo 8
Volvera 8
Auburn Hills 7
Haikou 7
Lappeenranta 7
Redwood City 7
Seattle 7
Athens 6
Hangzhou 6
Latisana 6
London 6
Moscow 6
Guangzhou 5
Orange 5
Palermo 5
Taizhou 5
Bari 4
Changchun 4
Fairfield 4
Ferrara 4
Groningen 4
Los Angeles 4
Menlo Park 4
Quarto 4
Rocca di Capri Leone 4
Altamura 3
Amman 3
Assago 3
Berlin 3
Brescia 3
Castellammare Di Stabia 3
Cinisello Balsamo 3
Edinburgh 3
Lanzhou 3
Manchester 3
Montesarchio 3
Parma 3
Perugia 3
Pomigliano D'arco 3
Portici 3
Tappahannock 3
Amsterdam 2
Atripalda 2
Bacoli 2
Boydton 2
Brdo 2
Catania 2
Corciano 2
Darmstadt 2
Davao City 2
Dearborn 2
Ercolano 2
Florence 2
Hefei 2
Huddersfield 2
Mantovana 2
Totale 7.344
Nome #
Endocardite infettiva (EI) nei tossicodipendenti ( IVDU): prevalenza del coinvolgimento del cuore sinistro e cambiamenti del profilo microbiologico 164
Hepatocellular carcinoma in chronic HBV-HCV co-infection is correlated to fibrosis and disease duration 89
Endocardite Infettiva da Streptococcus bovis: risultati dello Studio Endocarditi Italiano (SEI) 78
Anticorpi anti-fosfolipidi nell’endocardite infettiva: possibile ruolo nel determinismo delle complicanze emboliche 72
Anti-envelope 1 and 2 immune response in chronic hepatitis C patients: Effects of hepatitis B virus co-infection and interferon treatment 71
Nocardiosi polmonare in pazienti con trapianto di cuore: casi clinici 70
Caratteristiche attuali dell'endocardite infettiva in Italia: risultati dello Studio Endocarditi Italiano (SEI) 69
Association between surgical indications, operative risk, and clinical outcome in infective endocarditis: a prospective study from the International Collaboration on Endocarditis. 64
20210 G/A prothrombin gene mutation in patients with ischemic heart disease 64
Three-phase sequential combined treatment with lamivudine and interferon in young patients with chronic hepatitis B 61
Efficacia e sicurezza della combinazione colistina-rifampicina in confronto con la colistina in monoterapia nelle infezioni gravi da Acinetobacter baumannii MDR: risultati preliminari 61
Differential expression of toll-like receptor mRNA in treatment non-responders and sustained virologic responders at baseline in patients with chronic hepatitis C 60
A case of destructive infective endocarditis 60
Infective endocarditis due to high-level gentamicin and glycopeptides resistant enterococci: efficacy of the ampicillin-fluoroquinolones combination 59
Celiachia silente in pazienti con epatite C: prevalenza, effetto del trattamento con alfa-interferone sull’attivazione della malattia ed evoluzione clinica 59
Utilità dell'esame colturale ed isto-patologico della valvola nell'endocardite infettiva 59
Yellow nail syndrome as a cause of unexplained edema 58
Treatment of pulmonary nocardiosis in heart-transplant patients: importance of susceptibility studies 58
Factor V Leiden and glycoprotein IIIa PlA2 polymorphism in coronary thrombosis 58
Leukocyte interferon-alpha and ribavirin for treatment of chronic hepatitis C patients intolerant to pegylated-interferon 57
Ruolo patogenetico dell'adiponectina nella steatosi associata ad epatite C 57
A case of coagulopathy of unclear definition 57
Interferon-induced anti-HBE seroconversion correlates with a Th1 cytokine shift following emergence of core promoter mutations in chronic hepatitis B 56
Effects of growth hormone therapy in Becker patients with dilated cardiomyopathy 56
Association Between Valvular Surgery and Mortality Among Patients With Infective Endocarditis Complicated by Heart Failure 56
Factor V Leiden in patients with acute coronary syndromes 55
Unusually high rate of hepatic comorbidity with Streptococcus bovis endocarditis: trend or coincidence? 54
Multivalve involvement in infective endocarditis in the International Collaboration on Endocarditis prospective cohort study 54
Alterazioni istopatologiche epatiche in pazienti con cardiomiopatia dilatativa: prevalenza e correlazioni con l’etiologia della patologia cardiaca 54
Epatopatia cronica ed endocardite infettiva: risultati dello studio endocardite italiano (SEI) 54
Oral presentation: Clinical characteristics and 1 year outcome of cardiac device infective endocarditis 53
Infezioni polmonari micotiche e da nocardia nel paziente cardiotrapiantato: caratteristiche cliniche e trattamento 53
Comunicazione orale: Cinetica precoce dell’HCV-RNA in pazienti con epatite cronica: correlati clinico-virologici e valore predittivo la risposta al trattamento antivirale 53
Adefovir treatment for chronic hepatitis B in heart transplant recipients. 53
Antibiotic treatment of infections caused by carbapenem-resistant Gram-negative bacilli: an international ESCMID cross-sectional survey among infection diseases specialists practicing in large hospitals 53
Impact of early valve surgery on outcome of Staphylococcus aureus prosthetic valve infective endocarditis: analysis in the International Collaboration of Endocarditis-Prospective Cohort Study. 52
A preliminary randomized study of growth hormone administration in Becker and Duchenne muscular dystrophies 52
Comunicazione orale: Association of plasma homocysteine levels with infective endocarditis. 52
Heart failure in infective endocarditis: a report from the multicenter, prospective, observational Study on Endocarditis in Italy (SEI) 52
Infective endocarditis on cardiac rhythm management devices: preliminary study on the possible pathogenic role of inherited thrombophilias 52
Severe diarrhea occurring during alpha-interferon treatment for chronic hepatitis C is associated with serologic markers of celiac disease 52
Mutato spettro clinico della endocardite infettiva in persone tossicodipendenti 52
Antistaphylococcal β-Lactams versus Vancomycin for Treatment of Infective Endocarditis Due to Methicillin-Susceptible Coagulase-Negative Staphylococci: a Prospective Cohort Study from the International Collaboration on Endocarditis 52
Insulin resistance and steatosis in HBV-HCV co-infected patients: Role of PNPLA3 polymorphisms and impact on liver fibrosis progression. 51
Mild chronic hepatitis C with steatosis: Which treatment? 51
Alterazioni istopatologiche epatiche in pazienti con cardiomiopatia dilatativa: prevalenza e correlazioni con l’etiologia della patologia cardiaca 51
Oral presentation: Clinical features and outcome of patients with vascular prostheses infection 51
Sicurezza ed efficacia del trattamento con Peg-interferone e Ribavirina in pazienti con epatite C e cardiopatia strutturale 51
Major embolic events in infective endocarditis are associated with a younger age 51
Trapianto cardiaco non complicato in paziente con infezione da HIV 51
Oral presentation: Treatment of Duchenne dystrophy: results of 7 years cloprednol oral administration 51
Correlation of serum HBeAg levels and double A1762T/G1764A HBV core promoter mutation with response to interferon in patients with chronic hepatitis B 51
Growth hormone evaluation in patients with dystrophinopathic muscular dystrophy and dilated cardiomyopathy 51
Defective synthesis of granulocyte-colony stimulating factor in pegylated interferon-alpha treated chronic hepatitis C patients with declining leukocyte counts 50
Ruolo dell’asse GH/IGF-1 nella fisiopatologia e nella terapia cardiovascolare: lezioni da studi sull’animale 50
Ruolo patogenetico dell’adiponectina nella steatosi associata ad epatite C 50
Prevalence of pro-thrombotic genetic polymorphisms in infective endocarditis 50
Rhodococcus equi as a cause of Infective Endocarditis: description of 2 clinical cases 50
Inherited thrombophilia as a risk factor for infective endocarditis on cardiac rhythm management devices 50
Growth hormone improves left ventricular loading conditions in Becker Muscular Dystrophy 50
Hepatic steatosis and insulin resistance are associated with serum imbalance of adiponectin/tumour necrosis factor-alpha in chronic hepatitis C patients 49
Normal erythropoietin response in chronic hepatitis C patients with ribavirin-induced anaemia 49
Short-term effective bactericidal treatment of pulmonary nocardiosis in heart-transplant patients: importance of susceptibility studies 49
Comunicazione orale: Prevalenza e correlati della sindrome metabolica in soggetti cardio-trapiantati 49
CD1d-restricted non-invariant T lymphocytes in hepatitis C: a novel population of intra-hepatic lymphocytes 49
Features of infective endocarditis in persons on chronic hemodialysis. Results from the prospective, observational SEI study (Italian Study on Endocarditis) 49
Factors affecting hospital mortality in critically ill patients with multi-drug resistant Acinetobacter baumannii 49
Correlates and prognostic value of the first-phase hepatitis C virus RNA kinetics during treatment 48
Successful control of bleeding with recombinant activated factor VII (FVIIa) after cardiac re-transplantation in a patient on aggressive antiplatelet treatment 48
Multinational clinical experience with high dose daptomycin for the treatment of native valve endocarditis (NVE) 48
Infective endocarditis (IE) in intra-venous drug users (IVDU): prevalence of left heart involvement and changing microbiologic profile 48
Rapida ed accurata definizione eziologica mediante real time PCR in un grave caso di polmonite 48
Current trends in infective endocarditis in Italy: report on 852 cases from the multicenter, prospective SEI study 48
Inherited Hyper-Homocysteinemia as a Cause of Non-Bacterial Thrombotic Endocarditis 48
Safety and efficacy of peginterferon alpha plus ribavirin in patients with chronic hepatitis C and coexisting heart disease 48
Microsomal triglyceride transfer protein (MTP) -493G/T gene polymorphism contributes to fat liver accumulation in HCV genotype 3 infected patients 47
Management of Gram-negative and fungal endocarditis 47
Right diaphragm paralysis following cardiac radiofrequency catheter ablation for inappropriate sinus tachycardia 47
In-hospital death according to dementia diagnosis in acutely ill elderly patients: the REPOSI study. 47
Comunicazione orale: Platelet glycoprotein receptor polymorphisms in infective endocarditis: prevalence and pathophysiological significance 47
Comunicazione orale: Embolia maggiore nell’endocardite infettiva: associazione con l’età e la risposta di fase acuta 47
Comunicazione orale: Experience with high-doses of daptomycin in 50 patients with infective endocarditis. 47
Comunicazione orale: Hepatitis C virus core antigen serum levels during chronic infection and treatment: pathogenic implications and clinical significance 47
Infective endocarditis in intravenous drug users: prevalence of left heart involvement and changing microbiological profile 47
Correlates and prognostic value of the degree of heart failure in infective endocarditis. Results from the International Collaboration on Endocarditis Prospective Cohort Study 47
First-phase HCV-RNA kinetic during antiviral therapy for chronic hepatitis C: clinical and virological correlates and predictive value for treatment outcome 47
Clinical characteristics and outcome of a consecutive series of patients with vascular prosthesis infection: a single center report 47
Successful control of bleeding with recombinant activated factor VII (FVIIa) after cardiac re-transplantation in a patient on aggressive antiplatelet treatment 47
Successful outcome of aortic valve replacement in a patient with Niemann-Pick disease 47
Epatite acuta da HCV genotipo 3h: caratterizzazione virologica basale e monitoraggio “on therapy” 47
Risk factors for "major" embolic events in hospitalized patients with infective endocarditis 46
In-hospital and 1-year mortality in patients undergoing early surgery for prosthetic valve endocarditis. 46
A European first: Successful heart transplant in a human immunodeficiency virus-positive recipient 46
Embolia maggiore nell’endocardite infettiva: associazione con l’età e la risposta di fase acuta 46
Anticorpi anti-fosfolipidi nell’endocardite infettiva: possibile ruolo nel determinismo delle complicanze emboliche 46
Comunicazione orale: Trapianto cardiaco non complicato in paziente con infezione da HIV 46
Major embolic events in infective endocarditis are associated with a younger age 46
Embolic complications of infective endocarditis (IE): report on 709 IE episodes of the Italian Study on Endocarditis (SEI) 46
Endocardite infettiva su elettrocateteri intracardiaci: studio preliminare sul possibile ruolo patogenico della trombofilia ereditaria 46
Functional significance of GP1b alpha receptor polymorphism in patients with coronary artery disease 46
Totale 5.377
Categoria #
all - tutte 49.189
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.189


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201962 0 0 0 0 0 0 0 0 0 19 22 21
2019/20201.483 314 289 26 10 285 31 311 33 71 46 53 14
2020/20212.408 138 4 282 161 402 8 312 273 23 368 293 144
2021/20221.883 71 15 9 31 688 13 29 58 62 87 152 668
2022/20233.801 369 58 22 331 381 327 25 260 1.818 36 83 91
2023/20241.228 144 45 67 90 596 136 54 74 10 12 0 0
Totale 12.810